美股市場個股詳情

AEZS 依特鈉

添加自選
  • 1.9562
  • -0.0038-0.19%
收盤價 04/26 16:00 (美東)
  • 1.9500
  • -0.0062-0.32%
盤後 16:28 (美東)
949.91萬總市值-573市盈率TTM

關於依特鈉公司

苩erna Zentaris, Inc. operates as a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests. Its product Macimorelin, is an oral growth hormone secretagogue receptor agonist indicated for the diagnosis of Adult Growth Hormone Deficiency. The company was founded on September 12, 1990 and is headquartered in Charleston, SC.

公司介紹

公司代碼AEZS
公司名稱依特鈉
上市日期2000/05/10
成立日期1990
CEODr. Klaus Paulini
所屬市場納斯達克
員工數量21
證券類型海外普通股
年結日12-31
公司地址315 Sigma Drive,Summerville
城市Charleston
省份南卡羅來納州
國家美國
郵編29486
電話1-843-900-3223
網址http://www.zentaris.com

董事高管

  • 姓名
  • 職務
  • 年薪
  • Dr. Klaus Paulini
  • Director, President and Chief Executive Officer; Managing Director, AEZS Germany
  • 58.40萬
  • Nicola Ammer
  • Chief Medical Officer and Senior Vice President, Clinical Development
  • 16.80萬
  • Dr. Michael Teifel
  • Senior Vice President, Non Clinical Development and Chief Scientific Officer
  • 3.71萬
  • Giuliano La Fratta
  • Senior Vice President and Chief Financial Officer
  • 26.73萬
  • Dr. Matthias Gerlach
  • Senior Vice President, Manufacturing and Supply Chain
  • --
  • Carolyn Egbert
  • Chairman of the Board
  • 17.30萬
  • Dennis Turpin
  • Director
  • 15.80萬
  • Peter G. Edwards
  • Independent Director
  • 14.05萬
  • Gilles Gagnon
  • Independent Director
  • 6.25萬

分析

分析師評級

暫無數據

目標價預測

暫無數據

熱議
美股
綜合熱度
股票代碼
最新價
漲跌幅